Abbott India Ltd Stock Price Today (NSE: ABBOTINDIA)
Fundamental Score
Abbott India Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Abbott India Ltd share price today is ₹25915.00, down 1.02% on NSE/BSE as of 30 March 2026. Abbott India Ltd (ABBOTINDIA) is a Large-cap company in the Pharmaceuticals sector with a market capitalisation of ₹63.36K (Cr). The 52-week high for ABBOTINDIA share price is ₹37000.00 and the 52-week low is ₹25350.00. At a P/E ratio of 41.99x, ABBOTINDIA is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 35.68% and a debt-to-equity ratio of 0.05.
Abbott India Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Abbott India Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Abbott Share Price: A Financial Stability Analysis
The Indian pharmaceutical sector, experiencing robust growth driven by increasing healthcare awareness and access, presents a compelling landscape for investment. In this context, this analysis examines the financial stability of Abbott India Ltd, focusing on the current Abbott share price of ₹27365.0. This assessment forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, designed to evaluate the company's financial standing. The analysis is observational and does not constitute investment advice.
Abbott India Ltd boasts a Price-to-Earnings (PE) ratio of 41.99. While this figure might appear high at first glance, a deeper dive into the company’s performance relative to its peers is crucial. When we consider
Mankind Pharma Ltd, the differences in management quality and strategic direction can influence the market's perception and willingness to pay a premium. A higher PE may indicate investor confidence in Abbott's future growth prospects. It is important to note that different companies and their peer groups have distinct management styles. For example, differences in leadership strategy or innovative R&D implementation may affect the PE multiple.One of Abbott's most impressive metrics is its Return on Capital Employed (ROCE) of 46.25%. This high ROCE is a powerful indicator of the company's efficiency in generating profits from its capital investments. The high ROCE helps strengthen the company's moat. A sustained high ROCE gives Abbott greater financial flexibility, it allows them to re-invest in product development and market expansion organically. The company is also able to have a stronger balance sheet with increased efficiency. This in turn reinforces its competitive advantages in the market.
Finally, the stock's performance should always be viewed in context of the broader market and specific industry trends. Assessing factors such as regulatory changes, competitor activity, and overall economic conditions are key to forming a holistic perspective of Abbott's financial stability. The figures provided, including the PE ratio and ROCE, provide valuable insights but should be considered alongside other relevant factors for a complete understanding of the company's financial health. Peer comparisons to companies like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd should also be considered.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Abbott India Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ABBOTINDIA across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (35.68%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (46.25%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (23.71%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Excellent EPS Growth (18.98% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (18.98% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (103.78x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹4591.58 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (74.99%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 41.99x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Limited Institutional Interest (FII+DII: 9.27%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Abbott India Ltd Financial Statements
Comprehensive financial data for Abbott India Ltd including income statement, balance sheet and cash flow
About ABBOTINDIA (Abbott India Ltd)
Abbott India Ltd is a prominent player in the Indian pharmaceutical landscape, dedicated to delivering a diverse portfolio of healthcare solutions. With a legacy rooted in innovati...on and patient-centricity, the company focuses on addressing critical health needs across various therapeutic areas. Abbott India's commitment extends to providing high-quality medicines and solutions accessible to a broad spectrum of the Indian population. Through strategic collaborations and a robust research and development pipeline, the company continues to enhance its offerings, striving to improve the lives of individuals and contribute to a healthier nation. Its presence resonates with trust and reliability, solidifying its position as a leading pharmaceutical organization in India. The company's pharmaceutical products cater to a wide range of medical specialties, encompassing areas like gastroenterology, women's health, metabolic disorders, and central nervous system conditions. It offers solutions for conditions like insomnia, vitamin D deficiency, and pre-term labor, and chronic pain management. Abbott India also manufactures and sells vaccines to prevent infections and protect populations. This diverse portfolio reflects a comprehensive approach to healthcare, addressing both prevalent and emerging medical challenges in the country. By focusing on innovation and quality, Abbott India ensures that patients have access to effective and reliable treatments, improving overall health outcomes and well-being. Beyond its core therapeutic areas, Abbott India extends its pharmaceutical reach into segments like anti-infectives, cardio-diabetology, gastrointestinal and hepatology, hormones, neuropsychiatry, respiratory illnesses, and neuroscience. In addition, Abbott India offers a range of products targeting hepatic conditions, metabolic disorders, and gennext healthcare needs, solidifying its commitment to holistic well-being. Furthermore, the company provides consumer healthcare products designed to promote preventative care and healthy living. Through this diverse range of solutions, Abbott India demonstrates its dedication to addressing a wide spectrum of health requirements, reinforcing its role as a trusted partner in India's healthcare ecosystem.
Company Details
Key Leadership
Corporate Events
Latest News
ABBOTINDIA Share Price: Frequently Asked Questions
What is the current share price of Abbott India Ltd (ABBOTINDIA)?
As of 30 Mar 2026, 12:04 pm IST, Abbott India Ltd share price is ₹25915.00. The ABBOTINDIA stock has a market capitalisation of ₹63.36K (Cr) on NSE/BSE.
Is ABBOTINDIA share price Overvalued or Undervalued?
ABBOTINDIA share price is currently trading at a P/E ratio of 41.99x, compared to the industry average of 31.77x. Based on this relative valuation, the Abbott India Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of ABBOTINDIA share price?
The 52-week high of ABBOTINDIA share price is ₹37000.00 and the 52-week low is ₹25350.00. These values are updated daily from NSE/BSE price data.
What factors affect the Abbott India Ltd share price?
Key factors influencing ABBOTINDIA share price include quarterly earnings growth (Sales Growth: 7.62%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Abbott India Ltd a good stock for long-term investment?
Abbott India Ltd shows a 5-year Profit Growth of 18.98% and an ROE of 35.68%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.05 before investing in ABBOTINDIA shares.
How does Abbott India Ltd compare with its industry peers?
Abbott India Ltd competes with major peers in the Pharmaceuticals. Investors should compare ABBOTINDIA share price P/E of 41.99x and ROE of 35.68% against the industry averages to determine competitive standing.
What is the P/E ratio of ABBOTINDIA and what does it mean?
ABBOTINDIA share price has a P/E ratio of 41.99x compared to the industry average of 31.77x. Investors pay ₹42 for every ₹1 of annual earnings.
How is ABBOTINDIA performing according to Bull Run's analysis?
ABBOTINDIA has a Bull Run fundamental score of 65/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ABBOTINDIA belong to?
ABBOTINDIA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Abbott India Ltd share price.
What is Return on Equity (ROE) and why is it important for ABBOTINDIA?
ABBOTINDIA has an ROE of 35.68%, which indicates excellent management efficiency. ROE measures how efficiently Abbott India Ltd generates profits from shareholders capital.
How is ABBOTINDIA debt-to-equity ratio and what does it indicate?
ABBOTINDIA has a debt-to-equity ratio of 0.05, which indicates conservative financing with low financial risk.
What is ABBOTINDIA dividend yield and is it a good dividend stock?
ABBOTINDIA offers a dividend yield of 1.59%, meaning you receive ₹1.59 annual dividend for every ₹100 invested in Abbott India Ltd shares.
How has ABBOTINDIA share price grown over the past 5 years?
ABBOTINDIA has achieved 5-year growth rates of: Sales Growth 9.38%, Profit Growth 18.98%, and EPS Growth 18.98%.
What is the promoter holding in ABBOTINDIA and why does it matter?
Promoters hold 74.99% of ABBOTINDIA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Abbott India Ltd.
What is ABBOTINDIA market capitalisation category?
ABBOTINDIA has a market capitalisation of ₹63358 crores, placing it in the Large-cap category.
How volatile is ABBOTINDIA stock?
ABBOTINDIA has a beta of N/A. A beta > 1 suggests the Abbott India Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ABBOTINDIA operating profit margin trend?
ABBOTINDIA has a 5-year average Operating Profit Margin (OPM) of 23.71%, indicating the company's operational efficiency.
How is ABBOTINDIA quarterly performance?
Recent quarterly performance shows Abbott India Ltd YoY Sales Growth of 7.62% and YoY Profit Growth of 15.80%.
What is the institutional holding pattern in ABBOTINDIA?
ABBOTINDIA has FII holding of 0.16% and DII holding of 9.11%. Significant institutional holding often suggests professional confidence in the Abbott India Ltd stock.